全文获取类型
收费全文 | 123435篇 |
免费 | 8448篇 |
国内免费 | 448篇 |
专业分类
耳鼻咽喉 | 1628篇 |
儿科学 | 3293篇 |
妇产科学 | 2067篇 |
基础医学 | 15817篇 |
口腔科学 | 2362篇 |
临床医学 | 12462篇 |
内科学 | 25986篇 |
皮肤病学 | 1907篇 |
神经病学 | 11907篇 |
特种医学 | 4267篇 |
外国民族医学 | 4篇 |
外科学 | 17975篇 |
综合类 | 1875篇 |
现状与发展 | 1篇 |
一般理论 | 167篇 |
预防医学 | 10989篇 |
眼科学 | 2897篇 |
药学 | 8684篇 |
2篇 | |
中国医学 | 172篇 |
肿瘤学 | 7869篇 |
出版年
2023年 | 470篇 |
2022年 | 309篇 |
2021年 | 2060篇 |
2020年 | 1227篇 |
2019年 | 2012篇 |
2018年 | 2318篇 |
2017年 | 1787篇 |
2016年 | 1957篇 |
2015年 | 2412篇 |
2014年 | 3438篇 |
2013年 | 5330篇 |
2012年 | 7760篇 |
2011年 | 8281篇 |
2010年 | 4687篇 |
2009年 | 4509篇 |
2008年 | 7967篇 |
2007年 | 8513篇 |
2006年 | 8349篇 |
2005年 | 8637篇 |
2004年 | 8169篇 |
2003年 | 7999篇 |
2002年 | 7571篇 |
2001年 | 1179篇 |
2000年 | 927篇 |
1999年 | 1228篇 |
1998年 | 1703篇 |
1997年 | 1424篇 |
1996年 | 1161篇 |
1995年 | 1145篇 |
1994年 | 928篇 |
1993年 | 939篇 |
1992年 | 742篇 |
1991年 | 696篇 |
1990年 | 658篇 |
1989年 | 608篇 |
1988年 | 557篇 |
1987年 | 531篇 |
1986年 | 536篇 |
1985年 | 658篇 |
1984年 | 816篇 |
1983年 | 810篇 |
1982年 | 1143篇 |
1981年 | 1034篇 |
1980年 | 936篇 |
1979年 | 449篇 |
1978年 | 562篇 |
1977年 | 531篇 |
1976年 | 431篇 |
1975年 | 397篇 |
1974年 | 355篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
4.
5.
6.
7.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献8.
9.
10.
Li Bai Saeha Shin Richard T. Burnett Jeffrey C. Kwong Perry Hystad Aaron van Donkelaar Mark S. Goldberg Eric Lavigne Scott Weichenthal Randall V. Martin Ray Copes Alexander Kopp Hong Chen 《International journal of cancer. Journal international du cancer》2020,146(9):2450-2459
Lung and female breast cancers are highly prevalent worldwide. Although the association between exposure to ambient fine particulate matter (PM2.5) and lung cancer has been recognized, there is less evidence for associations with other common air pollutants such as nitrogen dioxide (NO2) and ozone (O3). Even less is known about potential associations between these pollutants and breast cancer. We conducted a population-based cohort study to investigate the associations of chronic exposure to PM2.5, NO2, O3 and redox-weighted average of NO2 and O3 (Ox) with incident lung and breast cancer, using the Ontario Population Health and Environment Cohort (ONPHEC), which includes all long-term residents aged 35–85 years who lived in Ontario, Canada, 2001–2015. Incident lung and breast cancers were ascertained using the Ontario Cancer Registry. Annual estimates of exposures were assigned to the residential postal codes of subjects for each year during follow-up. We used Cox proportional-hazards models adjusting for personal- and neighborhood-level covariates. Our cohorts for lung and breast cancer analyses included ~4.9 million individuals and ~2.5 million women, respectively. During follow-up, 100,146 incident cases of lung cancer and 91,146 incident cases of breast cancer were diagnosed. The fully adjusted analyses showed positive associations of lung cancer incidence with PM2.5 (hazard ratio [HR] = 1.02 [95% CI: 1.01–1.05] per 5.3 μg/m3) and NO2 (HR = 1.05 [95% CI: 1.03–1.07] per 14 ppb). No associations with lung cancer were observed for O3 or Ox. Relationships between PM2.5 and NO2 with lung cancer exhibited a sublinear shape. We did not find compelling evidence linking air pollution to breast cancer. 相似文献